Please login to the form below

Not currently logged in
Email:
Password:

International life sciences partnership

UK and US life sciences bodies agree to collaborate and promote closer interaction

The Golden Triangle Partnership (GTP), a joint collaboration between the three primary UK life sciences and healthcare networking organisations in Cambridge, London and Oxford, has signed a Memorandum of Understanding (MOU) with BIOCOM, the Southern California life science industry association in the US. BIOCOM is the largest regional life science association in the world, representing more than 550 member companies in that area.

The MOU, announced today at the BIO conference in Chicago, will encourage collaboration between the life science industry in the Golden Triangle and Southern California, promoting international member interaction and business-to-business activity.

"The Golden Triangle Partnership represents 80 per cent of the UK life science industry, providing members with real opportunities to network, partner and collaborate," said Harriet Fear, chief executive of the Eastern Region Biotechnology Initiative (ERBI), which is based in Cambridge and represents 350 members from the pharmaceutical, biotech, medical device and diagnostic fields.

Additionally, GTP and BIOCOM will promote each other's investment and partnering events to their respective members, as well as offering their members reduced rates to each other's signature events. 

"This MOU builds on the GTP's existing collaborations with MassBio and MasMEDIC to extend our network to the US West Coast. The intention is to increase deal flow with companies and investors in Southern California by facilitating introductions and presenting opportunities," commented Tony Jones, Director of the London Biotechnology Network.

"This is an historic initiative linking the Golden Triangle to the hugely active Southern California life sciences community which will provide valuable opportunities for our members," added Jon Rees, chief executive of the Oxfordshire Bioscience Network (OBN).

Joe Panetta, president and CEO of BIOCOM commented: "Southern California and the Golden Triangle are the two most active life science clusters in the world. We are delighted to offer our members opportunities to collaborate and partner with the UK's leading life sciences companies."

ERBI and London Biotechnology Network (LBN) announced last week that they are merging to form a single entity, with offices in Cambridge and London. The new organisation combines a wide range of life science industry sectors, representing commercial, clinical and academic interests, with 60 per cent of the UK's life science industry base, four of the UK's five Academic Health Science Centres and three of the world's top six universities.

The combined group will operate under the ERBI name, until the launch of a new identity at the ERBI annual conference on June 2.

5th May 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics